Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: A systematic review and meta‐analysis
- 25 October 2021
- journal article
- review article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 22 (12) , 695-705
Abstract
Objective: In this systematic review and meta‐analysis we aimed to determine the efficacy and safety of magnetic sphincter augmentation (MSA) in the management of refractory gastroesophageal reflux disease (rGERD).Methods: Literature search was conducted in PubMed, the Cochrane Library, EMBASE, Web of Science, OpenGrey and ClincalTrials.gov for single‐arm studies evaluating the efficacy and safety of MSA in rGERD or comparative studies with proton pump inhibitor (PPI) or laparoscopic Nissen fundoplication (LNF) serving as the control published until April 2020. Primary outcome was the rate of postoperative PPI use, and secondary outcomes included postoperative GERD‐health‐related quality of life (GERD‐HRQL), normalization of acid exposure time (AET) and incidence of procedure‐related adverse events (AE).Results: Ten single‐arm studies, one randomized controlled trial and three cohort studies involving 1138 participants were included. Post‐MSA PPI withdrawal, significant GERD‐HRQL improvement and AET normalization were achieved in 87.0%, 88.0% and 75.0% of the patients, respectively. The incidence of postoperative dysphagia was 29% and endoscopic dilation was required in 7.4% of patients undergoing MSA. MSA showed a better efficacy in symptom control than PPI (PPI cessation: 91% vs 0%; GERD‐HRQL improvement: 81% vs 8%) and similar effectiveness but a lower risk of gas‐bloat syndrome (risk ratio [RR] 0.69, 95% confidence interval [CI] 0.51‐0.93, P = 0.01) and better reserved ability to belch (RR 1.48, 95% CI 0.76‐2.86, P = 0.25) compared with LNF.Conclusions: MSA was an effective and safe therapy for rGERD. Well‐designed randomized trials that compare the efficacy of MSA with other therapies are needed.Keywords
Funding Information
- Guangdong Medical Research Foundation (A2019510)
- National Natural Science Foundation of China (81970479)
This publication has 37 references indexed in Scilit:
- Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational studySurgical Endoscopy, 2014
- Short-Term Outcomes Using Magnetic Sphincter Augmentation Versus Nissen Fundoplication for Medically Resistant Gastroesophageal Reflux DiseaseThe Annals of Thoracic Surgery, 2014
- A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplicationSurgical Endoscopy, 2014
- Introduction of Mechanical Sphincter Augmentation for Gastroesophageal Reflux Disease into Practice: Early Clinical Outcomes and Keys to Successful AdoptionJournal of the American College of Surgeons, 2014
- Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux diseaseDiseases of the Esophagus, 2014
- One Hundred Consecutive Patients Treated with Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease: 6 Years of Clinical Experience from a Single CenterJournal of the American College of Surgeons, 2013
- Esophageal Sphincter Device for Gastroesophageal Reflux DiseaseNew England Journal of Medicine, 2013
- LINX™Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux diseaseExpert Review of Gastroenterology & Hepatology, 2012
- The LINX® reflux management system: confirmed safety and efficacy now at 4 yearsSurgical Endoscopy, 2012
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996